Literature DB >> 12875988

Classification and subtype prediction of adult soft tissue sarcoma by functional genomics.

Neil H Segal1, Paul Pavlidis, Cristina R Antonescu, Robert G Maki, William S Noble, Diann DeSantis, James M Woodruff, Jonathan J Lewis, Murray F Brennan, Alan N Houghton, Carlos Cordon-Cardo.   

Abstract

Adult soft tissue sarcomas are a heterogeneous group of tumors, including well-described subtypes by histological and genotypic criteria, and pleomorphic tumors typically characterized by non-recurrent genetic aberrations and karyotypic heterogeneity. The latter pose a diagnostic challenge, even to experienced pathologists. We proposed that gene expression profiling in soft tissue sarcoma would identify a genomic-based classification scheme that is useful in diagnosis. RNA samples from 51 pathologically confirmed cases, representing nine different histological subtypes of adult soft tissue sarcoma, were examined using the Affymetrix U95A GeneChip. Statistical tests were performed on experimental groups identified by cluster analysis, to find discriminating genes that could subsequently be applied in a support vector machine algorithm. Synovial sarcomas, round-cell/myxoid liposarcomas, clear-cell sarcomas and gastrointestinal stromal tumors displayed remarkably distinct and homogenous gene expression profiles. Pleomorphic tumors were heterogeneous. Notably, a subset of malignant fibrous histiocytomas, a controversialhistological subtype, was identified as a distinct genomic group. The support vector machine algorithm supported a genomic basis for diagnosis, with both high sensitivity and specificity. In conclusion, we showed gene expression profiling to be useful in classification and diagnosis, providing insights into pathogenesis and pointing to potential new therapeutic targets of soft tissue sarcoma.

Entities:  

Mesh:

Year:  2003        PMID: 12875988      PMCID: PMC1868218          DOI: 10.1016/S0002-9440(10)63696-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Knowledge-based analysis of microarray gene expression data by using support vector machines.

Authors:  M P Brown; W N Grundy; D Lin; N Cristianini; C W Sugnet; T S Furey; M Ares; D Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Gastrointestinal stromal tumor workshop.

Authors:  J Berman; T J O'Leary
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

3.  Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Authors:  C R Antonescu; S J Tschernyavsky; R Decuseara; D H Leung; J M Woodruff; M F Brennan; J A Bridge; J R Neff; J R Goldblum; M Ladanyi
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

4.  Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile.

Authors:  S V Allander; N N Nupponen; M Ringnér; G Hostetter; G W Maher; N Goldberger; Y Chen; J Carpten; A G Elkahloun; P S Meltzer
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

5.  Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.

Authors:  Cristina R Antonescu; Sylvia J Tschernyavsky; James M Woodruff; Achim A Jungbluth; Murray F Brennan; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

6.  Multiclass cancer diagnosis using tumor gene expression signatures.

Authors:  S Ramaswamy; P Tamayo; R Rifkin; S Mukherjee; C H Yeang; M Angelo; C Ladd; M Reich; E Latulippe; J P Mesirov; T Poggio; W Gerald; M Loda; E S Lander; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

Review 7.  Chromosomal translocations in sarcomas: prospects for therapy.

Authors:  O Tomescu; F G Barr
Journal:  Trends Mol Med       Date:  2001-12       Impact factor: 11.951

8.  Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray.

Authors:  Satoshi Nagayama; Toyomasa Katagiri; Tatsuhiko Tsunoda; Taisuke Hosaka; Yasuaki Nakashima; Nobuhito Araki; Katsuyuki Kusuzaki; Tomitaka Nakayama; Tadao Tsuboyama; Takashi Nakamura; Masayuki Imamura; Yusuke Nakamura; Junya Toguchida
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

9.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

10.  Molecular characterisation of soft tissue tumours: a gene expression study.

Authors:  Torsten O Nielsen; Rob B West; Sabine C Linn; Orly Alter; Margaret A Knowling; John X O'Connell; Shirley Zhu; Mike Fero; Gavin Sherlock; Jonathan R Pollack; Patrick O Brown; David Botstein; Matt van de Rijn
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

View more
  58 in total

1.  CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.

Authors:  Junwei Chen; Tianhua Guo; Lei Zhang; Li-Xuan Qin; Samuel Singer; Robert G Maki; Takahiro Taguchi; Ronald Dematteo; Peter Besmer; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2011-11-10       Impact factor: 5.006

Review 2.  Role of gene expression arrays in sarcomas.

Authors:  Keith M Skubitz; Amy P N Skubitz
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

3.  NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Cristina R Antonescu; Ronald P DeMatteo; Kristen N Ganjoo; Robert G Maki; Peter W T Pisters; Chandrajit P Raut; Richard F Riedel; Scott Schuetze; Hema M Sundar; Jonathan C Trent; Jeffrey D Wayne
Journal:  J Natl Compr Canc Netw       Date:  2010-04       Impact factor: 11.908

Review 4.  [Sarcoma gene signatures].

Authors:  F Chibon; J-M Coindre
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

5.  Novel MIR143-NOTCH fusions in benign and malignant glomus tumors.

Authors:  Juan-Miguel Mosquera; Andrea Sboner; Lei Zhang; Chun-Liang Chen; Yun-Shao Sung; Hsiao-Wei Chen; Narasimhan P Agaram; Daniel Briskin; Basma M Basha; Samuel Singer; Mark A Rubin; Thomas Tuschl; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2013-09-02       Impact factor: 5.006

6.  Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.

Authors:  Anne M Mills; Andrew H Beck; Kelli D Montgomery; Shirley X Zhu; Inigo Espinosa; Cheng-Han Lee; Subbaya Subramanian; Christopher D Fletcher; Matt van de Rijn; Robert B West
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

Review 7.  Molecular profiling of sarcomas: new vistas for precision medicine.

Authors:  Tariq Al-Zaid; Wei-Lien Wang; Neeta Somaiah; Alexander J Lazar
Journal:  Virchows Arch       Date:  2017-06-29       Impact factor: 4.064

8.  Overexpression of atypical protein kinase C in HeLa cells facilitates macropinocytosis via Src activation.

Authors:  Ellen J Tisdale; Assia Shisheva; Cristina R Artalejo
Journal:  Cell Signal       Date:  2014-02-27       Impact factor: 4.315

9.  Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.

Authors:  Elai Davicioni; Michael J Anderson; Friedrich Graf Finckenstein; James C Lynch; Stephen J Qualman; Hiroyuki Shimada; Deborah E Schofield; Jonathan D Buckley; William H Meyer; Poul H B Sorensen; Timothy J Triche
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

10.  Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.

Authors:  A H Beck; C-H Lee; D M Witten; B C Gleason; B Edris; I Espinosa; S Zhu; R Li; K D Montgomery; R J Marinelli; R Tibshirani; T Hastie; D M Jablons; B P Rubin; C D Fletcher; R B West; M van de Rijn
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.